USFDA issues three observations each on API, Finished Product side of Lupin Pithampur facility Ruchika Sharma28 Sept 2024 12:15 PM ISTMumbai: Lupin has announced that the United States Food and Drug Administration (USFDA) has issued three observations each on the API and...
Lupin arm ink pact with Celnova for distribution of Orphan Drug NaMuscla in Argentina, Colombia Ruchika Sharma28 Sept 2024 11:10 AM ISTMumbai: Global pharma major, Lupin Limited has announced that its subsidiary Lupin Atlantis Holdings SA has entered into a distribution agreement...
Lupin bags USFDA nod for Bumetanide Injection for edema treatment Ruchika Sharma19 Sept 2024 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Lupin, Dr Reddy's Labs recall products in US over manufacturing issues: USFDA Ruchika Sharma5 Sept 2024 1:30 PM ISTNew Delhi: Pharma majors Lupin, Dr Reddy's Laboratories are recalling products in the US over manufacturing issues, according to a latest...
Lupin launches Mirabegron Extended-Release Tablets in US Ruchika Sharma4 Sept 2024 8:30 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Mirabegron Extended-Release Tablets, 50 mg, in the United States, after having...
Lupin unveils generic cancer drug in US Ruchika Sharma30 Aug 2024 1:00 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50...
USFDA nod to Lupin Brimonidine Tartrate Ophthalmic Solution Ruchika Sharma28 Aug 2024 1:30 PM ISTBrimonidine Tartrate Ophthalmic Solution, 0.1% indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma.
Lupin bags Health Canada nod for biosimilar Pegfilgrastim Ruchika Sharma25 Aug 2024 2:00 PM ISTArmlupeg is available in a form of pre-filled syringe of 6mg/0.6 ml.
Lupin secures USFDA tentative nod for Brimonidine Tartrate Ophthalmic Solution Ruchika Sharma17 Aug 2024 11:33 AM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Lupin Australia arm incorporates new subsidiary in New Zealand Ruchika Sharma10 Aug 2024 11:00 AM ISTMumbai: Through a recent BSE filing, Lupin has informed that Generic Health Pty Ltd., Australia, a wholly owned subsidiary of the Company, has...
Lupin Announces Positive Results from Global Phase 3 Trial of Lucentis Biosimilar Lalhmangaihkimi8 Aug 2024 10:46 AM ISTLupin recently announced positive results from global phase 3 clinical trials evaluating the immunogenicity, safety, and efficacy of LUBT010—Lupin's...
Lupin incorporates new subsidiary Lupin Lanka in Sri Lanka Ruchika Sharma7 Aug 2024 1:58 PM ISTMumbai: Lupin Ltd. has incorporated Lupin Lanka (Private) Ltd., Sri Lanka, as wholly owned subsidiary of the Company.The Company will make...
